Amy Goundry Takes on The Role of Managing Editor for Therapeutic Advances in Cardiovascular Disease
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”I’ve recently taken on the role of Managing Editor for Therapeutic Advances in Cardiovascular Disease, a gold open access journal dedicated to advancing clinical care across the full spectrum of cardiac and circulatory conditions.
The journal is shaped by a global community of researchers and clinicians who care about evidence that informs real treatment decisions — from pharmacological innovations to interventional strategies and other therapeutic approaches that move us closer to precision cardiovascular care.
Always glad to connect with researchers and clinicians helping to shape the conversation in cardiovascular care — whether by sharing their research or contributing to the journal’s editorial community!”
Find the Journal here.
Stay updated with Hemostasis Today.
-
Nov 25, 2025, 14:18From Ticagrelor to Prasugrel․ ISAR-REACT 5 Findings Redefine Clinical Practice
-
Nov 25, 2025, 12:03Ana Rita Rodrigues on Post-Stroke Oropharyngeal Dysphagia
-
Nov 25, 2025, 11:01Jack Shuang Hou: Asundexian Hits Phase 3 Stroke Endpoint Without Increasing Bleeding Risk
-
Nov 25, 2025, 10:37Moin Makda: HemeNext Felt Like a Full Circle Moment
-
Nov 25, 2025, 10:14Lucas Di Meglio and Team Show That Targeting Extracellular DNA Mayy Reduce Microvascular Thrombosis
-
Nov 25, 2025, 09:54Hema Tallman on BioLife Plasma Services Leaders Spreading Holiday Cheer through Volunteerism
-
Nov 25, 2025, 09:36Stefan Hof on The Role of Pyrrolidine Dithiocarbamate in Hemorrhagic Shoke
-
Nov 25, 2025, 09:29Ashkan Shoamanesh: Should Intracranial Hemorrhage Survivors with AFib Receive Anticoagulation?
-
Nov 25, 2025, 09:20Christian Schulze on The Role of TEE versus CT in the Detection of Left Atrial Thrombi